-
Feb.212022NEWS
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer
-
Jan.212022NEWS
HanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update
HanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update
-
Dec.062021NOTICE
HanAll to Present at Korea Bio Investment Conference 2021
HanAll to Present at Korea Bio Investment Conference 2021
-
Oct.272021NEWS
HanAll Biopharma Reports Third Quarter 2021 Results
HanAll Biopharma Reports Third Quarter 2021 Results
-
Oct.202021NEWS
HanAll\'s Partner HBM Completes First Dosing of Phase 2 of Batoclimab in TED in China
HanAll\'s Partner HBM Completes First Dosing of Phase 2 of Batoclimab in TED in China
-
Sep.022021NEWS
HanAll\'s Partner HBM Announces IND Approval for Phase 2 of Batoclimab in CIDP in China
HanAll\'s Partner HBM Announces IND Approval for Phase 2 of Batoclimab in CIDP in China